Background A significant proportion of individuals experience lingering and debilitating
symptoms following acute COVID-19 infection. The National Institute for Health and Care …

Persistent breathlessness> 28 days after acute COVID-19 infection has been identified as a
highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms …

Individuals with lasting symptoms of COVID-19 should be offered a comprehensive recovery
programme. 30 individuals (mean [SD] age 58 [16]) that completed a 6 week, twice …

Importance The long-term health outcomes and symptom burden of COVID-19 remain
largely unclear. Objective To evaluate health outcomes of COVID-19 survivors 1 year after …

Importance Relatively little is known about the persistence of symptoms in patients with
COVID-19 for more than 1 year after their acute illness. Objective To assess the health …

Background To systematically evaluate the prevalence of post-sequelae and chronic
obstructive pulmonary disease assessment test (CAT) scoring one year after hospital …

The aim of the study was to evaluate the effectiveness of breathing exercises given by
telemedicine in post-Covid-19 dyspneic individuals. Individuals in the intervention group (n …

The human coronavirus 2019 disease (COVID-19) and the associated acute respiratory
distress syndrome (ARDS) are responsible for the worst global health crisis of the last …

Moreover, Paxlovid use had an effect on CAT scores >= 10 in the subgroup of elderly
patient group, male patient group, without vaccine received group, the non-COPD group …

Background Dyspnea is common after COVID‐19. Though the underlying mechanisms are
largely unknown, lung perfusion abnormalities could contribute to lingering dyspnea …